BREANN LEAMER: Open Payments
NPI 1922355007 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$437 in 22 payments from 5 companies in 2025. Trend: 2023 $915 · 2024 $590 · 2025 $437
Food & beverage: $437
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 16 | $311 |
| Astellas Pharma US Inc | 3 | $59 |
| IMMUNITYBIO, INC. | 1 | $25 |
| UROGEN PHARMA, INC. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
Products named: ORGOVYX, Xtandi, GEMTESA, ANKTIVA, Nubeqa.
Industry payments across PA — which companies pay providers there.
